Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBAT-MI: Combination Therapy in Myocardial Infarction
NCT02404376Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Mar 2016
- Primary completion
- Aug 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of exenatide in ST-elevation myocardial infarction (STEMI), sponsored by Vall d'Hebron Research Institute. Started Mar 2016; status: completed.
02
Drugs
exenatide
03
Conditions
ST-elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02404376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404376.